A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation
Autor: | Webster, Lynn, Dhar, Sunita, Eldon, Michael, Masuoka, Lorianne, Lappalainen, Jaakko, Sostek, Mark |
---|---|
Zdroj: | In Pain September 2013 154(9):1542-1550 |
Databáze: | ScienceDirect |
Externí odkaz: |